Baxter International (BAX) | Financial Analysis & Statements

Baxter International Inc. | Large-cap | Healthcare

$31.72

2.82%

| Baxter International Stock Comparison:

Baxter International vs Intuitive Surgical Baxter International vs Becton, Dickinson Baxter International vs Alcon Baxter International vs ResMed Baxter International vs West Pharmaceutical Baxter International vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 10.6B

Gross Profit 4.0B 37.46%

Operating Income 439.0M 4.13%

Net Income -638.0M -6.00%

EPS (Diluted) -$1.27

Balance Sheet Metrics

Total Assets 25.8B

Total Liabilities 18.8B

Shareholders Equity 7.0B

Debt to Equity 2.67

Cash Flow Metrics

Operating Cash Flow 409.0M

Free Cash Flow 559.0M

Revenue & Profitability Trend

Baxter International Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	10.6B	14.8B	14.5B	12.1B	11.7B
Cost of Goods Sold	6.7B	9.8B	9.4B	7.4B	7.1B
Gross Profit	4.0B	5.0B	5.1B	4.7B	4.6B
Operating Expenses	3.5B	4.6B	4.5B	3.4B	3.0B
Operating Income	439.0M	370.0M	605.0M	1.3B	1.6B
Pre-tax Income	-289.0M	-103.0M	-2.6B	1.1B	1.3B
Income Tax	37.0M	-34.0M	4.0M	83.0M	182.0M
Net Income	-638.0M	2.7B	-2.4B	1.3B	1.1B
EPS (Diluted)	-$1.27	$5.25	-$4.83	$2.53	$2.13

Income Statement Trend

Baxter International Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	8.9B	9.6B	8.0B	8.9B	8.4B
Non-Current Assets	16.9B	18.7B	20.3B	24.6B	11.6B
Total Assets	25.8B	28.3B	28.3B	33.5B	20.0B
Liabilities
Current Liabilities	6.5B	6.5B	4.7B	4.2B	3.3B
Non-Current Liabilities	12.2B	13.3B	17.6B	20.2B	8.0B
Total Liabilities	18.8B	19.8B	22.4B	24.4B	11.3B
Equity
Total Shareholders Equity	7.0B	8.5B	5.9B	9.1B	8.7B

Balance Sheet Composition

Baxter International Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	-326.0M	-69.0M	-2.7B	1.0B	1.1B
Operating Cash Flow	409.0M	801.0M	-2.0B	1.7B	1.6B
Investing Activities
Capital Expenditures	-	-	-	-	-
Investing Cash Flow	50.0M	20.0M	-252.0M	-10.5B	-470.0M
Financing Activities
Dividends Paid	-590.0M	-586.0M	-573.0M	-530.0M	-473.0M
Financing Cash Flow	-1.2B	-3.6B	-1.6B	8.1B	-547.0M
Free Cash Flow	559.0M	1.0B	591.0M	1.5B	1.2B

Cash Flow Trend

Baxter International Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 133.76

Forward P/E 10.41

Price to Book 2.17

Price to Sales 1.43

PEG Ratio 10.41

Profitability Ratios

Profit Margin -5.20%

Operating Margin 9.75%

Return on Equity -3.51%

Return on Assets 2.50%

Financial Health

Current Ratio 2.02

Debt to Equity 146.14

Beta 0.61

Per Share Data

EPS (TTM) -$0.52

Book Value per Share $13.80

Revenue per Share $21.08

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
bax	15.4B	133.76	2.17	-3.51%	-5.20%	146.14
Intuitive Surgical	184.6B	75.42	10.79	15.96%	28.41%	0.00
Becton, Dickinson	48.6B	32.89	1.93	5.89%	7.18%	76.34
Alcon	42.8B	38.45	1.95	5.23%	11.28%	23.63
ResMed	37.3B	28.60	6.73	25.81%	26.15%	15.14
West Pharmaceutical	16.0B	34.96	5.96	17.42%	16.13%	11.46

Financial data is updated regularly. All figures are in the company's reporting currency.